Andlauer Healthcare Group Inc.
AND.TO · TSX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.20 | 1.75 | 2.42 | 2.99 |
| FCF Yield | 1.49% | 1.63% | 1.06% | 1.73% |
| EV / EBITDA | 56.73 | 37.70 | 41.00 | 39.68 |
| Quality | ||||
| ROIC | 2.11% | 2.58% | 2.98% | 2.89% |
| Gross Margin | 22.86% | 22.13% | 23.47% | 23.33% |
| Cash Conversion Ratio | 2.67 | 1.63 | 1.29 | 1.88 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.11% | -0.47% | 0.11% | 1.89% |
| Free Cash Flow Growth | 19.76% | 45.14% | -33.51% | -26.57% |
| Safety | ||||
| Net Debt / EBITDA | 3.10 | 3.05 | 3.21 | 2.94 |
| Interest Coverage | 9.39 | 11.03 | 12.67 | 10.89 |
| Efficiency | ||||
| Inventory Turnover | 20.81 | 22.58 | 14.42 | 24.13 |
| Cash Conversion Cycle | 32.48 | 32.24 | 36.45 | 31.78 |